Prenatal and childhood exposure to tobacco smoking was associated with an increased risk for autoimmune disorders.

Researchers assessed the risk for serious infection during pregnancy and postpartum based on TNF inhibitor exposure among women with chronic inflammatory disease.

Early initiation of an intensive blood pressure control reduced the risk for MACE among older patients with hypertension.

Tea consumption is associated with higher total hip BMD in older women, while excessive coffee intake may adversely affect BMD.

Ultrasound-derived VAT demonstrated better predictive ability than BMI and waist circumference in hepato-metabolic assessment in MASLD.

The AHA recommended whole exome or whole genome sequencing as first-line diagnostic tools for mitochondrial diseases.

Use of liraglutide or semaglutide therapy does not increase risk for thyroid cancer among patients with type 2 diabetes or obesity.

West Nile virus is the leading mosquito-borne infection in the United States. Neuroinvasive disease affects less than 1% but it can be fatal.

GLP-1RA therapy significantly reduces the risk for new-onset heart failure in patients with T2D or obesity, regardless of weight loss.

Primary hyperparathyroidism is associated with increased long-term risks for hypertension, type 2 diabetes, and cardiovascular disease.

FDA grants Priority Review to teplizumab for patients aged 1 to 7 years with stage 2 type 1 diabetes to delay stage 3 onset.

Topline data from the phase 3 ATTAIN-MAINTAIN trial evaluated orforglipron for weight maintenance after initial treatment with Wegovy or Zepbound in adults with obesity or overweight.